MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy

Stem Cells

Volumn 32, Issue 2, 2014, Pages 447-461

  Bobadilla, Míriam ^a   Sáinz, Neira ^a   Rodriguez, Joséantonio ^a   Abizanda, Gloria ^a   Orbe, Josune ^a   De Martino, Alba ^b   Verdugo, Josémanuel García ^c   Páramo, José A ^a,d   Prósper, Felipe ^a,d   Pérez Ruiz, Ana ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Matrix metalloproteinase 10; Muscle regeneration; Notexin; Satellite cells

Indexed keywords

MATRIX METALLOPROTEINASE-10; MUSCLE REGENERATION; NOTEXIN; SATELLITE CELLS;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REGENERATION;

EID: 84894567956     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1553     Document Type: Article

References (57)

1. Emery AE. The muscular dystrophies. Lancet 2002;359: 687-695.
2. O'Brien KF, Kunkel LM. Dystrophin and muscular dystrophy: Past, present, and future. Mol Genet Metab 2001;74: 75-88.
3. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol 2003;2: 731-740.
4. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004;84: 209-238.
5. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17: 463-516.
6. Guerin CW, Holland PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. Dev Dyn 1995;202: 91-99.
7. Caron NJ, Asselin I, Morel G et al. Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice. Cell Transplant 1999;8: 465-476.
8. Ohtake Y, Tojo H, Seiki M. Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle. J Cell Sci 2006;119: 3822-3832.
9. Barkho BZ, Munoz AE, Li X et al. Endogenous matrix metalloproteinase (MMP)23 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008;26: 3139-3149.
10. Suzuki T, Mandai M, Akimoto M et al. The simultaneous treatment of MMP-2 stimulants in retinal transplantation enhances grafted cell migration into the host retina. Stem Cells 2006;24: 2406-2411.
11. Dennis RA, Zhu H, Kortebein PM et al. Muscle expression of genes associated with inflammation, growth, and remodeling is strongly correlated in older adults with resistance training outcomes. Physiol Genomics 2009;38: 169-175.
12. Rullman E, Rundqvist H, Wagsater D et al. A single bout of exercise activates matrix metalloproteinase in human skeletal muscle. J Appl Physiol 2007;102: 2346-2351.
13. Urso ML, Szelenyi ER, Warren GL et al. Matrix metalloprotease-3 and tissue inhibitor of metalloprotease-1 mRNA and protein levels are altered in response to traumatic skeletal muscle injury. Eur J Appl Physiol 2010; 109: 963-972.
14. Kherif S, Lafuma C, Dehaupas M et al. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: A study in experimentally injured and mdx muscles. Dev Biol 1999;205: 158-170.
15. Vincenti MP, Brinckerhoff CE. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: Can MMPs be good for you? J Cell Physiol 2007;213: 355-364.
16. Schultz G. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009;17: 153-162.
17. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004;16: 558-564.
18. Ebrahimian TG, Squiban C, Roque T et al. Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: Role in physiological and pathological wound healing. Stem Cells 2012;30: 1436-1446.
19. Chen X, Li Y. Role of matrix metalloproteinases in skeletal muscle: Migration, differentiation, regeneration and fibrosis. Cell Adh Migr 2009;3: 337-341.
20. Christov C, Chretien F, Abou-Khalil R et al. Muscle satellite cells and endothelial cells: Close neighbors and privileged partners. Mol Biol Cell 2007;18: 1397-1409.
21. Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 2003;278: 12601-12604.
22. Yamada H, Saito F, Fukuta-Ohi H et al. Processing of beta-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 2001;10: 1563-1569.
23. Kumar A, Bhatnagar S. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice. Am J Pathol 2010;177: 248-260.
24. Miyazaki D, Nakamura A, Fukushima K et al. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Hum Mol Genet 2011;20: 1787-1799.
25. Dahiya S, Bhatnagar S, Hindi SM et al. Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophindeficient mdx mice. Hum Mol Genet 2011;20: 4345-4359.
26. Montero I, Orbe J, Varo N et al. C-reactive protein induces matrix metalloproteinase-1 and 210 in human endothelial cells: Implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006;47: 1369-1378.
27. Rodriguez JA, Orbe J, Martinez de Lizarrondo S et al. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front Biosci 2008;13: 2916-2921.
28. Gill JH, Kirwan IG, Seargent JM et al. MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 2004;6: 777-785.
29. Orbe J, Rodriguez JA, Calvayrac O et al. Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation. Arterioscler Thromb Vasc Biol 2009;29: 2109-2116.
30. Orbe J, Barrenetxe J, Rodriguez JA et al. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombinactivatable fibrinolysis inhibitor-mediated mechanism. Circulation 2011;124: 2909-2919.
31. Nishimura T, Nakamura K, Kishioka Y et al. Inhibition of matrix metalloproteinases suppresses the migration of skeletal muscle cells. J Muscle Res Cell Motil 2008;29: 37-44.
32. Bedair H, Liu TT, Kaar JL et al. Matrix metalloproteinase-1 therapy improves muscle healing. J Appl Physiol 2007;102: 2338-2345.
33. Allamand V, Campbell KP. Animal models for muscular dystrophy: Valuable tools for the development of therapies. Hum Mol Genet 2000;9: 2459-2467.
34. Murphy MM, Lawson JA, Mathew SJ et al. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Development 2011;138: 3625-3637.
35. Gomes MD, Lecker SH, Jagoe RT et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001;98: 14440-14445.
36. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007;26: 587-596.
37. Fahling M, Steege A, Perlewitz A et al. Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochim Biophys Acta 2005;1731: 32-40.
38. Minakuchi Y, Takeshita F, Kosaka N et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 2004;32: e109.
39. Mias C, Lairez O, Trouche E et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 2009;27: 2734-2743.
40. Grounds MD, Davies M, Torrisi J et al. Silencing TNFalpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: An in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res 2005;320: 509-515.
41. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9: 493-495.
42. Zammit PS, Partridge TA, Yablonka-Reuveni Z. The skeletal muscle satellite cell: The stem cell that came in from the cold. J Histochem Cytochem 2006;54: 1177-1191.
43. Irintchev A, Zweyer M, Wernig A. Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscul Disord 1997;7: 117-125.
44. Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med 2010;48: 757-767.
45. Grounds MD. Towards understanding skeletal muscle regeneration. Pathol Res Pract 1991;187: 1-22.
46. Ocalan M, Goodman SL, Kuhl U et al. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev Biol 1988;125: 158-167.
47. Ohlendieck K, Campbell KP. Dystrophinassociated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 1991;115: 1685-1694.
48. Ross J, Benn A, Jonuschies J et al. Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse. Stem Cells 2012;30: 2330-2341.
49. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2009;106: 7991-7996.
50. Collins CA, Olsen I, Zammit PS et al. Stem cell function, self-renewal, and behav-ioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005;122: 289-301.
51. Hughes SM, Blau HM. Migration of myoblasts across basal lamina during skeletal muscle development. Nature 1990;345: 350-353.
52. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69: 562-573.
53. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4: 197-250.
54. Germani A, Di Carlo A, Mangoni A et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003; 163: 1417-1428.
55. Rotwein P, Wilson EM. Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol 2009;219: 503-511.
56. Rosenblatt JD, Lunt AI, Parry DJ et al. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 1995;31: 773-779.
57. Meyerholz DK, Griffin MA, Castilow EM et al. Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model. Toxicol Pathol 2009;37: 249-255.